Dr. Reddy’s Laboratories, one of India’s top drug makers by sales, has launched Atocor-R (Atorvastatin + Ramipril) in India. 

It is the first such combination to be approved by DCGI and has completed a multicenter clinical trial data on Indian Patients.

It is a one of its kind combination that has two blockbuster molecules, Atorvastatin and Ramipril combined together for the first time as a fixed dose combination. Atocor-R is used in the treatment of patients with both essential hypertension and hypercholesterolemia.

It is available in two fixed dose combinations of Atocor-R 2.5 (Atorvastatin 10mg + Ramipril 2.5 mg ) and Atocor-R 5 (Atorvastatin 10mg + ramipril 5 mg) and comes is packs of 10.